1-3 of 3
Vijay G. Bhoj
Close
Sort by
Journal Articles

Absolute lymphocyte count proliferation kinetics after CAR T-cell infusion impact response and relapse

Clinical Trials & Observations
Sophia Faude, Jane Wei, Kavitha Muralidharan, Xiaoming Xu, Gerald Wertheim, Michele Paessler, Vijay G. Bhoj, Stephan A. Grupp, Shannon L. Maude, Susan R. Rheingold, Vinodh Pillai
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2128–2136.
https://doi.org/10.1182/bloodadvances.2020004038
Published: 2021
Includes: Supplemental data
Journal Articles

Stable HLA antibodies following sustained CD19 + cell depletion implicate a long-lived plasma cell source

Clinical Trials & Observations
Zheng Zhang, Stephen J. Schuster, Simon F. Lacey, Michael C. Milone, Dimitri Monos, Vijay G. Bhoj
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4292–4295.
https://doi.org/10.1182/bloodadvances.2020002435
Published: 2020
Journal Articles

CAR T-cell therapy is effective for CD19-dim B-lymphoblastic leukemia but is impacted by prior blinatumomab therapy

Vinodh Pillai, Kavitha Muralidharan, Wenzhao Meng, Asen Bagashev, Derek A. Oldridge, Jaclyn Rosenthal, John Van Arnam, Jos J. Melenhorst, Diwakar Mohan, Amanda M. DiNofia, Minjie Luo, Sindhu Cherian, Jonathan R. Fromm, Gerald Wertheim, Andrei Thomas-Tikhonenko, Michele Paessler, Carl H. June, Eline T. Luning Prak, Vijay G. Bhoj, Stephan A. Grupp, Shannon L. Maude, Susan R. Rheingold
Journal: Blood Advances
Blood Adv (2019) 3 (22): 3539–3549.
https://doi.org/10.1182/bloodadvances.2019000692
Published: 2019
Includes: Supplemental data